{
  "ptid_time": "127_S_4197_2011-08-22",
  "img_path": "/data/qiuhui/data/adni/images/127_S_4197/2011-08-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,136 mm³, 58.7% above the reference mean. With a Z-score of 1.41 (92.0th percentile), this represents mild enlargement; hippocampal volume measures 6,584 mm³, 12.9% below the reference mean. With a Z-score of -1.26 (10.4th percentile), this represents mild atrophy; whole brain volume measures 1,103,650 mm³, 2.2% above the reference mean. With a Z-score of 0.29 (61.5th percentile), this represents normal volume ; entorhinal cortex volume measures 2,846 mm³, 30.6% below the reference mean. With a Z-score of -2.07 (1.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 19,888 mm³, 5.6% above the reference mean. With a Z-score of 0.47 (68.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,623 mm³, 6.0% above the reference mean. With a Z-score of 0.54 (70.6th percentile), this represents normal volume . ",
  "text_data": "Age is 79.3 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 30.0. MoCA: 25.0. Logical Memory: 7.0. Laboratory findings: Total Protein: 6.20 (significant reduced); Alkaline Phosphatase: 30.00 (significant reduced). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.52 SUVR (profound elevated); Amyloid beta: 555.40 pg/mL (mild reduced); Total tau: 201.10 pg/mL (normal ); Phosphorylated tau: 17.74 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The imaging shows significant atrophy in the entorhinal cortex (Z-score -2.07, 1.9th percentile) and mild hippocampal atrophy (Z-score -1.26, 10.4th percentile), both key regions in Alzheimer's pathology. Despite normal MMSE (30), the MoCA (25) suggests subtle cognitive impairment, and elevated AV45 (amyloid PET) with mildly reduced Aβ supports amyloid deposition.  \n\nDiagnosis: **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \nConfidence: **Medium** (clinical scores are borderline, but biomarker/imaging findings align with early Alzheimer’s changes).  \n\n*Note: Progression to dementia is likely given amyloid positivity and entorhinal atrophy, but current cognitive performance doesn’t yet meet dementia thresholds.*",
  "timestamp": "2025-07-26T13:13:59.396644"
}